COVID-19 Drug ‘Remdesivir’ Concerns, Potential Monday, May 11, 2020 | Sacramento, CA Listen / download audio Update RequiredTo play audio, update browser or Flash plugin. This illustration provided by the Centers for Disease Control and Prevention (CDC) in January 2020 shows the 2019 Novel Coronavirus (2019-nCoV).CDC via AP Remdesivir is a drug in clinical trials showing promise in reducing the severity of COVID-19 in those infected. It was recently approved by the U.S. FDA, and the government has said it's distributing the promising coronavirus drug to the hardest-hit areas of the country. Eventually, all 50 states will get it. We take a closer look at Remdesivir and its prospects as a longterm solution to the coronavirus. Guests UC Davis School of Veterinary Medicine Distinguished Professor Emeritus Dr. Niels Pedersen
